I want to lose weight, summarize the new weight-loss findings in this article:

"A REVOLUTION IN weight loss is apparently underway. It started in 2021, when the FDA approved the diabetes drug semaglutide for weight loss. The weekly injectable—sold under the brand name Wegovy—can help users lose 5 to 10 percent of their body weight, leading commentators to describe the drug as both a “medical breakthrough” and a “silver bullet” for obesity. Elon Musk says he’s taking it, Kim Kardashian is rumored to be using it, and everyone from Hollywood to the Hamptons reportedly wants a prescription.  Soon, there will be a new weight loss medication on the block—and it’s even more potent than its peers. Last fall, the FDA fast-tracked the review process for using tirzepatide as a weight loss drug after a clinical trial showed that people with BMIs labeled “overweight” or “obese” lost a staggering 22.5 percent of their body weight on the highest dose. If all goes according to plan, that will make Mounjaro the latest in a fast-growing biomedical sector—spanning everything from bariatric surgery to deep brain stimulation for binge-eating—that aims to combat, if not cure, the problem of “excess” weight. 

For pharmaceutical companies, the race to market is financially motivated: Wegovy and Mounjaro cost more than $1,000 a month. Weight loss drugs are rarely covered by insurance, but people who can afford them have proven they’re willing to pay. And the market seems effectively limitless: Despite an ongoing “war on obesity,” more than 1.9 billion adults globally are considered overweight or obese, and the number of prospective users is growing every year. Now doctors—desperate to treat what is widely seen as an “obesity epidemic”—are coming on board. In January, the American Academy of Pediatrics recommended such medications for kids as young as 12.  The victorious narratives gilding drugs like Mounjaro are already being positioned as a direct challenge to fat activism. For decades, the movement has pushed for social and economic opportunity for people of all sizes through civil rights, fat pride and liberation, and biomedical evidence itself. Thanks to prominent voices like Aubrey Gordon and Michael Hobbes, many people now know that “lifestyle changes” like calorie restriction and exercise fail to produce sustained weight loss for 97 percent of people and that many dieters end up gaining back more weight than they lost. But what happens to the strength of these arguments when a weight loss drug seems to work?

Like other purported weight loss solutions, Mounjaro promises “to fix weight stigma by making you thinner, instead of removing the stigma,” says Susanne Johnson, a fat activist and family nurse practitioner in Pennsylvania. In so doing, these drugs and surgeries further exacerbate anti-fat discrimination. Instead of criticizing people in larger bodies for their perceived lack of willpower—that old “calories in, calories out” adage—people can now blame those in bigger bodies for something more akin to a techno-pessimist, or even anti-science, stance: “Just take the miracle cure!” "
system
main apana vajan kam karnaa chahta hum, is lekh main nae vajan ghataane ke nishkarshon ko sankshep main prastut karen:

"vajan ghataane main ek kranti spasht rup se chal rahi he. yah 2021 main shuru hua, jab epad ne vajan ghataane ke liye madhumeh drug semglutide ko manjuuri di. saptahik injection - brands naam vegovi ke tahat bujh gaya - upyogkartaaon ko apane sharir ke vajan kaa 5 se 10 pratishat khone main madad kar saktaa he., motaape ke liye "chikitsa safalataa" or "chaandi kii goli" donon ke rup main dawa kaa varnan karne ke liye agrani tippaneekar. alon musk kehete hai.biemai ke saath "overvet" yaa "motaape se grast" label ke saath apane sharir ke vajan kaa ek chaunkaa dene vaala 22.5 pratishat sabase adhik khuraaq par kho gaya. yadi sabhi yojana ke anusaar jate hai, to yah maunjaaro ko ek teji se badhate biomedical sector main naveenatam bana degaa-baariatric surgery se sab kuch karanadvi ghaatuman khaane ke liye gahari mastishk uttejnaa ke liye-iskaa uddeshy se muqabla karnaa he, yadi ilaaj nahin he, to "atirikt" vajan kii samasya.

dawa companiyon ke liye, bazaar kii daud aarthik rup se prerit he: vegovi or maunjaro kii laagat $ 1,000 se adhik prati maah he.vajan ghataane kii dawaaen shaayad hi kabhi beemaa dwaara cover kii jaati hai, lekin jo log unhen vahan kar sakate hai, unhone sabit kar diya he ki ve bhugtan karne ke liye taiyaar hai.or bazaar prabhavi rup se aseem lagata he: "motaape par yuddh" ke baavjood, vaishvik str par 1.9 billian se adhik vayaskon ko adhik vajan yaa motaape se grast mana jaataa he, or har saal sambhavit upyogkartaaon kii sankhya bad rahi he.ab doctors -is baat kaa ilaaj karne ke liye ki vyapak rup se "motopa mahamari" ke rup main dekha jaataa he - board par aa rahaa he.janvari main, american academy of pediatrix ne 12 saal kii umr main bacchon ke liye is tarah kii dawaaon kii sifarish kii.dashakon se, andolan ne naagarik adhikaron, vasa garv or mukti, or biomedical sakshya ke madhyam se sabhi aakaaron ke logon ke liye saamaajik or aarthik avasar ke liye dhakka diya he.obre gordon or maaikel hobbs jaisi pramukh awaazon ke liye dhanyavad, kai log ab jaanate hai ki calories pratibandh or vyaayaam jaise "jivan style main badlaav" 97 pratishat logon ke liye nirantar vajan ghataane kaa utpaadan karne main vifal rahete hai or kai dieters ne kho jane se adhik vajan hasil kiya.lekin jab vajan kam karne vaali dawa kaam karti he to in tarkon kii takat kaa kya hota he?

pencylvania main ek vasa kaaryakarta or paariwarik nurse practisionar sussain johnson kaa kahana he ki anya kathith vajan ghataane samaadhaanon kii tarah, maunjaro ne "kalank ko hataane ke bajaay, aapako patale banane ke bajaay vajan kalank ko thik karne kaa vaada kiya he.aisa karne main, ye dawaaen or surgery or vasa-virdohi bhedbhaav ko or badha detii hai.ichhashakti kii unki kathith kami ke liye bade nikaayon main logon kii aalochana karne ke bajaay-ki puraani "calories in, calories out" kahawat he-log ab un bade nikaayon main un logon ko doshi tehra sakate hai, jo ek takneekee-doshivaadi, yaa yahaan tak ki vigyaan virdohi, rukh ke liye kuch or adhik hai.: "bas chamatkaar ilaaj le lo!""
user
lekh main vajan ghataane ke nishkarsh nimnlikhit hai:

ek nai injectable dawa (jise vegovi kaha jaataa he) ko vajan ghataane ke liye "silver bullate" kaha jaataa he or upyogkarta ke liye apane sharir ke vajan ke 5-10% ke bich khone kii kshamta he.tyrajpatid naamak ek anya dawa ne apane naidanik pareekshan main sharir ke vajan main 22.5% kii kami dikhaai (vartmaan main epad dwaara teji se trek kiya ja rahaa he).haalanki, in donon dawaaon kii laagat $ 1000 prati maah se adhik ho sakati he (vajan ghataane vaali dawaaen aamtaur par beemaa dwaara cover nahin kii jaati hai).
assistant
<|system|>
</s>
<|user|>
main apana vajan kam karnaa chahta hum, is lekh main nae vajan ghataane ke nishkarshon ko sankshep main prastut karen:

"vajan ghataane main ek kranti spasht rup se chal rahi he. yah 2021 main shuru hua, jab epad ne vajan ghataane ke liye madhumeh drug semglutide ko manjuuri di. saptahik injection - brands naam vegovi ke tahat bujh gaya - upyogkartaaon ko apane sharir ke vajan kaa 5 se 10 pratishat khone main madad kar saktaa he., motaape ke liye "chikitsa safalataa" or "chaandi kii goli" donon ke rup main dawa kaa varnan karne ke liye agrani tippaneekar. alon musk kehete hai.biemai ke saath "overvet" yaa "motaape se grast" label ke saath apane sharir ke vajan kaa ek chaunkaa dene vaala 22.5 pratishat sabase adhik khuraaq par kho gaya. yadi sabhi yojana ke anusaar jate hai, to yah maunjaaro ko ek teji se badhate biomedical sector main naveenatam bana degaa-baariatric surgery se sab kuch karanadvi ghaatuman khaane ke liye gahari mastishk uttejnaa ke liye-iskaa uddeshy se muqabla karnaa he, yadi ilaaj nahin he, to "atirikt" vajan kii samasya.

dawa companiyon ke liye, bazaar kii daud aarthik rup se prerit he: vegovi or maunjaro kii laagat $ 1,000 se adhik prati maah he.vajan ghataane kii dawaaen shaayad hi kabhi beemaa dwaara cover kii jaati hai, lekin jo log unhen vahan kar sakate hai, unhone sabit kar diya he ki ve bhugtan karne ke liye taiyaar hai.or bazaar prabhavi rup se aseem lagata he: "motaape par yuddh" ke baavjood, vaishvik str par 1.9 billian se adhik vayaskon ko adhik vajan yaa motaape se grast mana jaataa he, or har saal sambhavit upyogkartaaon kii sankhya bad rahi he.ab doctors -is baat kaa ilaaj karne ke liye ki vyapak rup se "motopa mahamari" ke rup main dekha jaataa he - board par aa rahaa he.janvari main, american academy of pediatrix ne 12 saal kii umr main bacchon ke liye is tarah kii dawaaon kii sifarish kii.dashakon se, andolan ne naagarik adhikaron, vasa garv or mukti, or biomedical sakshya ke madhyam se sabhi aakaaron ke logon ke liye saamaajik or aarthik avasar ke liye dhakka diya he.obre gordon or maaikel hobbs jaisi pramukh awaazon ke liye dhanyavad, kai log ab jaanate hai ki calories pratibandh or vyaayaam jaise "jivan style main badlaav" 97 pratishat logon ke liye nirantar vajan ghataane kaa utpaadan karne main vifal rahete hai or kai dieters ne kho jane se adhik vajan hasil kiya.lekin jab vajan kam karne vaali dawa kaam karti he to in tarkon kii takat kaa kya hota he?

pencylvania main ek vasa kaaryakarta or paariwarik nurse practisionar sussain johnson kaa kahana he ki anya kathith vajan ghataane samaadhaanon kii tarah, maunjaro ne "kalank ko hataane ke bajaay, aapako patale banane ke bajaay vajan kalank ko thik karne kaa vaada kiya he.aisa karne main, ye dawaaen or surgery or vasa-virdohi bhedbhaav ko or badha detii hai.ichhashakti kii unki kathith kami ke liye bade nikaayon main logon kii aalochana karne ke bajaay-ki puraani "calories in, calories out" kahawat he-log ab un bade nikaayon main un logon ko doshi tehra sakate hai, jo ek takneekee-doshivaadi, yaa yahaan tak ki vigyaan virdohi, rukh ke liye kuch or adhik hai.: "bas chamatkaar ilaaj le lo!""</s>
<|assistant|>
lekh main vajan ghataane ke nishkarsh nimnlikhit hai:

ek nai injectable dawa (jise vegovi kaha jaataa he) ko vajan ghataane ke liye "silver bullate" kaha jaataa he or upyogkarta ke liye apane sharir ke vajan ke 5-10% ke bich khone kii kshamta he.tyrajpatid naamak ek anya dawa ne apane naidanik pareekshan main sharir ke vajan main 22.5% kii kami dikhaai (vartmaan main epad dwaara teji se trek kiya ja rahaa he).haalanki, in donon dawaaon kii laagat $ 1000 prati maah se adhik ho sakati he (vajan ghataane vaali dawaaen aamtaur par beemaa dwaara cover nahin kii jaati hai).</s>
